Searchable abstracts of presentations at key conferences in endocrinology

ea0010oc4 | Reproduction, neuroendocrinology and diabetes | SFE2005

The 3D cytoarchitecture of the VTA and the size of its dopaminergiccell population are permanently altered by perinatalglucocorticoid exposure

McArthur S , McHale|G##Gillies E

By including the synthetic glucocorticoid (GC), dexamethasone, in the maternal drinking water on gestational days 16–19 (0.5 μg/ml) or days 1–7 after birth (1.0 μg/ml), we have recently demonstrated (McArthur et al. J. Neuroendocrinol. 17: 475) that perinatal exposure of rat pups to GCs increased dopaminergic (DA) cell numbers in the adult ventral tegmental area (VTA) at −5.1 to −5.4 mm relative to Bregma (level I). In order to investig...

ea0007s34 | Joint BES and EFES symposium: Neuroactive steroids: implications for disease and healthy ageing | BES2004

Sexual dimorphism and neuroprotection by sex steroids in an animal model of Parkinson's disease

Gillies G , Murray H , Dexter D , McArthur S

Epidemiological and clinical studies provide evidence for sex differences in the incidence or severity of certain neurological conditions. For example Parkinson's disease, which is characterised by a progressive degeneration of dopaminergic (DA) neurones in the substantia nigra pars compacta (SNc) and a reduction in DA levels in the striatum, is more prevalent in men than women. Therefore, our work aimed to establish whether physiological levels of sex steroid hormones confer ...

ea0006oc4 | Young Endocrinologist Session | SFE2003

Influence of Annexin 1 gene deletion on dopaminergic cell numbers in the mid-brain

Shah A , McArthur S , Morris J , Flower R , Buckingham J , Gillies G

There is now substantial evidence to suggest that the early life environment can have a permanent effect on adult physiology. Recently we have shown that early postnatal glucocorticoid (GC) exposure produces alterations in midbrain dopaminergic cell number in the adult rat, in a gender-specific manner (McArthur et al., Brit. Neurosci. Assoc. Abstr. 2003;17:27). Since the protein annexin 1 (ANXA1) mediates some aspects of the effects of GCs within the immune system and the hypo...

ea0004s21 | Journal of Endocrinology Symposium: Young Innovations - Society for Endocrinology Research Fellows Update | SFE2002

PERINATAL GLUCOCORTICOID TREATMENT, GROWTH AND THE GROWTH HORMONE AXIS

Warne J , Theogaraj E , John C , Houston P , Smith S , Gillies G , Buckingham J

It is well documented that inappropriate exposure to glucocorticoids (GCs) in early life stunts growth and predisposes the individual to metabolic disorders, including type 2 diabetes. Evidence suggests that these programming actions involve alterations in GC receptor expression. However, the precise mechanisms remain to be determined. As GCs are known to modify both the neuroendocrine control of growth hormone (GH) secretion and the peripheral effects of GH on growth and meta...

ea0004oc26 | Neuroendocrinology and diabetes | SFE2002

Pre- and postnatal dexamethasone treatment differentially alter the expression of annexin 1 and NOS-2 in adult rat thymus

Lamfon H , Theogaraj E , John C , Smith S , Gillies G , Buckingham J

Exposure to high levels of glucocorticoids (GCs) at critical stages in development is thought to compromise immune function in adulthood (1), but the underlying mechanisms are poorly understood. Accordingly, we have examined the effects of perinatal dexamethasone treatment on the expression in the adult thymus of (a) inducible nitric oxide synthase (NOS-2, paradoxically also expressed constitutively in the thymus) which liberates NO, a factor involved in the negative selection...